ArticlebioRxiv : the preprint server for biology2024
A genetically engineered therapeutic lectin inhibits human influenza A virus infection and sustains robust virus-specific CD8 T cell expansion.
Meng Yu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.